These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 23047907)

  • 1. [Metabolic interactions between the hyperhomocysteinemia and angiotensin-1 converting enzyme activity in Tunisian patients with coronary heart disease].
    Chalghoum A; Noichri Y; Chkioua L; Gammoudi I; Dandana A; Khelil S; Jeridi G; Baudin B; Ferchichi S; Miled A
    Ann Biol Clin (Paris); 2012 Oct; 70(5):599-604. PubMed ID: 23047907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pro-oxidant effect of angiotensin-1 converting enzyme in Tunisian patients with coronary heart disease.
    Chalghoum A; Noichri Y; Mohamed MH; Dandana A; Baudin B; Ferchichi S; Miled A
    Acta Biomed; 2012 Dec; 83(3):202-7. PubMed ID: 23762996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic interactions between hyperhomocysteinemia and endothelin-1 among Tunisian patients with acute coronary diseases.
    Chalghoum A; Noichri Y; Karkouch I; Dandana A; Baudin B; Jeridi G; Ferchichi S; Miled A
    Biol Res; 2015 Jun; 48(1):32. PubMed ID: 26103962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Homocysteine, lipoprotein (a): risk factors for coronary heart disease].
    Laraqui A; Bennouar N; Meggouh F; Allami A; El Kadiri N; Benkouka F; Azeddoug H; El Haitem N; Benomar A; Fellat S; Benomar M
    Ann Biol Clin (Paris); 2002; 60(5):549-57. PubMed ID: 12368140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hyperhomocysteinemia and schizophrenia: case control study].
    Mabrouk H; Douki W; Mechri A; Younes MK; Omezzine A; Bouslama A; Gaha L; Najjar MF
    Encephale; 2011 Sep; 37(4):308-13. PubMed ID: 21981892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Homocysteinemia and coronary artery disease: a case-control study in a Tunisian population].
    Souissi M; Feki M; Mourali S; Enneifer M; Omar S; Sanhaji H; Mechmeche R; Mebazaa A; Kaabachi N
    Arch Mal Coeur Vaiss; 2006 Sep; 99(9):781-5. PubMed ID: 17067095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The mechanisms of hyperhomocysteinemia in coronary heart disease].
    Gao W; Jiang N; Zhu G
    Zhonghua Yi Xue Za Zhi; 1998 Nov; 78(11):821-3. PubMed ID: 11038775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The C677T mutation in methylenetetrahydrofolate reductase gene, plasma homocysteine concentration and the risk of coronary artery disease.
    Kadziela J; Janas J; Dzielińska Z; Szperl M; Gaździk D; Chotkowska E; Piotrowski W; Ruzyłło W
    Kardiol Pol; 2003 Jul; 59(7):17-26; discussion 26. PubMed ID: 14560345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperhomocysteinemia and hyperlipidemia in coronary heart disease.
    Gao W; Jiang N; Meng Z; Tang J
    Chin Med J (Engl); 1999 Jul; 112(7):586-9. PubMed ID: 11601248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study of the intronic polymorphism of the angiotensin 1 converting enzyme among coronary Tunisians].
    Chalghoum A; Noichri Y; Chkioua L; Gammoudi I; Dandana A; Chahed H; Khelil S; Jeridi G; Baudin B; Ferchichi S; Miled A
    Ann Cardiol Angeiol (Paris); 2011 Jun; 60(3):135-40. PubMed ID: 21277558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma homocysteine levels in cardiovascular disease, malaria and protein-energy malnutrition in Sudan.
    Abdel GA; Abdullah SH; Kordofani AY
    East Mediterr Health J; 2009; 15(6):1432-9. PubMed ID: 20218135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Levels of homocysteine and polymorphisms of homocysteine metabolism-related enzymes in patients with type 2 diabetes mellitus and coronary heart disease].
    Luo D; Yan S; Cheng X; Song Y
    Wei Sheng Yan Jiu; 2009 Jan; 38(1):39-42. PubMed ID: 19267073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylenetetrahydrofolate reductase gene mutation and hyperhomocysteinemia as a risk factor for coronary heart disease in the Indian population.
    Nair KG; Nair SR; Ashavaid TF; Dalal JJ; Eghlim FF
    J Assoc Physicians India; 2002 May; 50 Suppl():9-15. PubMed ID: 12186157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Characteristics of hyperhomocysteinemia in dialysis patients].
    Lovcić V; Kes P; Reiner Z
    Acta Med Croatica; 2006; 60(1):21-6. PubMed ID: 16802568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelial function markers in parkinsonian patients with hyperhomocysteinemia.
    Bostantjopoulou S; Katsarou Z; Frangia T; Hatzizisi O; Papazisis K; Kyriazis G; Kiosseoglou G; Kazis A
    J Clin Neurosci; 2005 Aug; 12(6):669-72. PubMed ID: 16040247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hyperhomocysteinemia is frequent in coronary disease patients. Study of 202 patients].
    Fernández-Miranda C; Aranda JL; Gómez González P; Díaz-Rubio P; Estenoz J; Gómez de la Cámara A
    Med Clin (Barc); 1999 Oct; 113(11):407-10. PubMed ID: 10562951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathological interactions between the endothelin-1 and the angiotensin- converting enzyme among Tunisian coronary patients.
    Chalghoum A; Noichri Y; Dandana A; Baudin B; Miled A; Ferchichi S
    BMC Cardiovasc Disord; 2016 Nov; 16(1):244. PubMed ID: 27894250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of polymorphisms on key enzymes in homocysteine metabolism, on plasma homocysteine level and on coronary artery-disease risk in a Tunisian population].
    Belkahla R; Omezzine A; Kchok K; Rebhi L; Ben Hadj Mbarek I; Rejeb J; Ben Rejeb N; Slimane N; Nabli N; Ben Abdelaziz A; Boughzala E; Bouslama A
    Ann Cardiol Angeiol (Paris); 2008 Aug; 57(4):219-24. PubMed ID: 18620331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homocysteinemia correlates with plasma thiol redox status in patients with end-stage renal disease.
    Palleschi S; De Angelis S; Rossi B; Diana L; Papa V; Severini G; Splendiani G
    Nephron Clin Pract; 2008; 108(2):c106-12. PubMed ID: 18212512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperhomocysteinemia, paraoxonase concentration and cardiovascular complications in Tunisian patients with nondiabetic renal disease.
    Kerkeni M; Letaief A; Achour A; Miled A; Trivin F; Maaroufi K
    Clin Biochem; 2009 Jun; 42(9):777-82. PubMed ID: 19233152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.